Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Graft versus host disease10.02.01.027; 12.02.09.0010.003649%Not Available
Haematemesis24.07.02.011; 07.12.02.0020.027978%Not Available
Haematochezia24.07.02.012; 07.12.02.0030.055957%Not Available
Haematoma24.07.01.001--
Haemoglobin decreased13.01.05.003--Not Available
Haemolytic anaemia01.06.03.0020.020984%Not Available
Haemoptysis24.07.01.006; 22.02.03.004; 02.01.02.006--Not Available
Haemorrhage intracranial24.07.04.003; 17.08.01.008--
Hallucination19.10.02.0020.062951%
Hallucination, auditory19.10.02.0030.013989%Not Available
Hallucination, visual19.10.02.0040.020984%Not Available
Headache17.14.01.001--
Heart rate decreased13.14.04.0010.027978%Not Available
Heart rate increased13.14.04.0020.146886%Not Available
Hepatic cirrhosis09.01.04.0010.013989%Not Available
Hepatic encephalopathy17.13.01.003; 09.01.03.0060.003649%Not Available
Hepatic failure09.01.03.0020.009123%
Hepatic function abnormal09.01.02.0010.041967%Not Available
Hepatitis09.01.07.0040.125902%Not Available
Hepatitis B09.01.09.003; 11.05.06.0020.013989%
Hepatitis fulminant11.07.01.003; 09.01.07.0070.005474%Not Available
Hepatitis toxic12.03.01.016; 09.01.07.0170.020984%Not Available
Hepatocellular injury09.01.07.0080.048962%Not Available
Hepatotoxicity12.03.01.008; 09.01.07.0090.020984%Not Available
Herpes zoster23.09.03.002; 11.05.02.003--
Hiccups22.02.04.002; 07.01.06.0090.013989%
Hirsutism23.02.04.001; 05.05.01.005--
Hyperglycaemia05.06.02.002; 14.06.02.0020.132897%
Hyperhidrosis23.02.03.004; 08.01.03.0280.202843%
Hypernatraemia14.05.04.001--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 17 Pages